Previous Close | 3.1000 |
Open | 2.7500 |
Bid | 1.1100 |
Ask | 2.2500 |
Strike | 420.00 |
Expire Date | 2025-01-17 |
Day's Range | 2.7500 - 3.1000 |
Contract Range | N/A |
Volume | |
Open Interest | 377 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]